A MUTATION IN YEAST TOP2 HOMOLOGOUS TO A QUINOLONE-RESISTANT MUTATION IN BACTERIA - MUTATION OF THE AMINO-ACID HOMOLOGOUS TO SER(83) OF ESCHERICHIA-COLI GYRA ALTERS SENSITIVITY TO EUKARYOTIC TOPOISOMERASE INHIBITORS

被引:49
作者
HSIUNG, YC
ELSEA, SH
OSHEROFF, N
NITISS, JL
机构
[1] ST JUDE CHILDRENS RES HOSP, DEPT MOLEC PHARMACOL, MEMPHIS, TN 38101 USA
[2] CHILDRENS HOSP LOS ANGELES, DIV HEMATOL ONCOL, DEV THERAPEUT SECT, LOS ANGELES, CA 90027 USA
[3] UNIV SO CALIF, SCH MED, DEPT BIOCHEM & MOLEC BIOL, LOS ANGELES, CA 90089 USA
[4] VANDERBILT UNIV, SCH MED, DEPT BIOCHEM, NASHVILLE, TN 37232 USA
[5] VANDERBILT UNIV, SCH MED, DEPT MED, NASHVILLE, TN 37232 USA
关键词
D O I
10.1074/jbc.270.35.20359
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In prokaryotic type II topoisomerases (DNA gyrases), mutations that result in resistance to quinolones frequently occur at Ser(83) or Ser(84) of the gyrA subunit. Mutations to Trp, Ala, and Leu have been identified, all of which confer high levels of quinolone resistance. Extensive segments of DNA gyrase are homologous to eukaryotic topoisomerase II, and Ser(741) of yeast TOP2 is homologous to Ser(83) of prokaryotic DNA gyrA. Introduction of the Ser(741) --> Trp mutation into yeast TOP2 confers resistance to 6,8-difluoro 7-(4'-hydroxyphenyl)-1-cyclopropyl-4-quinolone-3 carboxylic acid (CP 115,953), a fluoroquinolone with substantial activity against eukaryotic topoisomerase II, whereas changing Ser(741) to either Leu or Ala does not change sensitivity to quinolones. Interestingly, Ser(741) --> Trp in the yeast TOP2 also confers hypersensitivity to etoposide. Sensitivity to intercalating anti topoisomerase II agents such as amsacrine is not changed by any of the three mutations. The topoisomerase II protein carrying the Ser(741) --> Trp mutation was overexpressed and purified. The purified mutant enzyme had enhanced levels of etoposide stabilized covalent complex as compared with the wild type enzyme and reduced cleavage with CP-115,953. Unlike the wild type enzyme, etoposide-stabilized cleavage is not readily reversible by heat. We suggest that Ser(741) is near a binding site for both quinolones and etoposide and that the Ser(741) --> Trp mutation leads to a more stable ternary complex between etoposide, DNA, and the mutant enzyme.
引用
收藏
页码:20359 / 20364
页数:6
相关论文
共 34 条
[1]  
Beck W T, 1991, Semin Cancer Biol, V2, P235
[2]  
CORBETT AH, 1993, J BIOL CHEM, V268, P14394
[3]   WHEN GOOD ENZYMES GO BAD - CONVERSION OF TOPOISOMERASE-II TO A CELLULAR TOXIN BY ANTINEOPLASTIC DRUGS [J].
CORBETT, AH ;
OSHEROFF, N .
CHEMICAL RESEARCH IN TOXICOLOGY, 1993, 6 (05) :585-597
[4]  
Cozzarelli N. R., 1990, DNA TOPOLOGY ITS BIO
[5]   TOPOISOMERASE-TARGETING ANTITUMOR DRUGS [J].
DARPA, P ;
LIU, LF .
BIOCHIMICA ET BIOPHYSICA ACTA, 1989, 989 (02) :163-177
[6]   INHIBITORS OF DNA TOPOISOMERASES [J].
DRLICA, K ;
FRANCO, RJ .
BIOCHEMISTRY, 1988, 27 (07) :2253-2259
[7]   DRUG FEATURES THAT CONTRIBUTE TO THE ACTIVITY OF QUINOLONES AGAINST MAMMALIAN TOPOISOMERASE-II AND CULTURED-CELLS - CORRELATION BETWEEN ENHANCEMENT OF ENZYME-MEDIATED DNA CLEAVAGE IN-VITRO AND CYTOTOXIC POTENTIAL [J].
ELSEA, SH ;
MCGUIRK, PR ;
GOOTZ, TD ;
MOYNIHAN, M ;
OSHEROFF, N .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (10) :2179-2186
[8]   A YEAST TYPE-II TOPOISOMERASE SELECTED FOR RESISTANCE TO QUINOLONES - MUTATION OF HISTIDINE-1012 TO TYROSINE CONFERS RESISTANCE TO NONINTERCALATIVE DRUGS BUT HYPERSENSITIVITY TO ELLIPTICINE [J].
ELSEA, SH ;
HSIUNG, YC ;
NITISS, JL ;
OSHEROFF, N .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (04) :1913-1920
[9]  
ELSEA SH, 1992, J BIOL CHEM, V267, P13150
[10]  
GIAEVER G, 1986, J BIOL CHEM, V261, P2448